The US health regulator has issued an import alert for the human and animal medicines made by Gujarat-based Pan Drugs Ltd for violation of manufacturing norms.
According to information available on the United States Food and Drug Administration (USFDA) website, the regulator has issued import alert on drugs, including anti-biotics, for both human and animals manufactured by the company for (GMP) Good Manufacturing Practices violations.
Under the alert 66-40, the USFDA has the rights for detention without physical examination of drugs from firms which have not met drug GMPs.
Pan Drugs is a manufacturer of active pharmaceutical ingredients.
Last month, the USFDA had issued warning letter to India's second-largest drug maker Dr Reddy's relating to two of its API manufacturing plants and a formulation plant in Andhra Pradesh and Telangana.
